Annual report pursuant to Section 13 and 15(d)

Statements of Operations and Comprehensive Loss

v3.24.1
Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating expenses:    
Research and development $ 55,424 $ 39,300
General and administrative 19,236 14,839
Total operating expenses 74,660 54,139
Loss from operations (74,660) (54,139)
Other income:    
Interest income 6,985 1,164
Net loss (67,675) (52,975)
Other comprehensive income (loss):    
Net unrealized income (loss) on available-for-sale investments, net of tax 86 (47)
Net comprehensive loss $ (67,589) $ (53,022)
Net loss per share of voting and non-voting common stock, basic $ (1.65) $ (1.81)
Net loss per share of voting and non-voting common stock, diluted $ (1.65) $ (1.81)